GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹192 Cr | ₹137 Cr | ₹122 Cr | ₹19 Cr | ₹23 Cr |
What is the latest Net Current Assets ratio of GENNEX LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹192 Cr |
| Mar2025 | ₹137 Cr |
| Mar2024 | ₹122 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹23 Cr |
How is Net Current Assets of GENNEX LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹192 Cr | 40.77 | |
| Mar2025 | ₹137 Cr | 12.40 | |
| Mar2024 | ₹122 Cr | 533.85 | |
| Mar2023 | ₹19 Cr | -16.56 | |
| Mar2022 | ₹23 Cr | - | |
Compare Net Current Assets of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹218.6 Cr | 9.6% | -9.7% | -43.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | 9.6% |
-9.7% |
-43.7% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses